Market Tracker

09/23 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

12.09
Delayed Data
As of Sep 23
 -0.31 / -2.50%
Today’s Change
6.96
Today|||52-Week Range
18.65
-30.24%
Year-to-Date
Bullish & Bearish Reversals for the Week
Sep 19 / TheStreet.com - Paid Partner Content
Netflix Can Break out Soon
Sep 19 / TheStreet.com - Paid Partner Content
Halozyme Therapeutics (HALO) Catches Eye: Stock Up 7.9%
Sep 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close12.40
Today’s open12.38
Day’s range12.07 - 12.47
Volume1,568,635
Average volume (3 months)1,342,437
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-263.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book36.03

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.32+0.59%
XLRNAcceleron Pharma Inc-0.50-1.25%
CHRSCoherus BioSciences ...-0.88-2.85%
ONCESpark Therapeutics I...-1.99-3.20%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts